Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REMDESIVIR vs REPAGLINIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REMDESIVIR vs REPAGLINIDE: Safety Overview

Metric REMDESIVIR REPAGLINIDE
Total FAERS Reports 10,501 2,544
Deaths Reported 2,729 169
Death Rate 26.0% 6.6%
Hospitalizations 2,556 1,517
Average Patient Age 61.7 yrs 71.9 yrs
% Female Patients 39.8% 45.5%
FDA Approval Date Oct 22, 2020 Apr 24, 2015
Manufacturer Gilead Sciences, Inc. Rising Pharma Holdings, Inc.
Route INTRAVENOUS ORAL
Marketing Status Prescription Discontinued